Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV associated thrombotic microangiopathy.

S Ahmed1, R K Siddiqui, A K Siddiqui

  • 1Division of Hematology and Oncology, Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, NY, USA.

Postgraduate Medical Journal
|October 3, 2002
PubMed
Summary

Thrombotic microangiopathy (TMA) is a serious complication of HIV infection, often presenting with low platelets and anemia. Prompt diagnosis and plasma exchange are vital for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery.

British journal of anaesthesia·2008
Same author

Cavitary lung masses in SLE patients: an unusual manifestation of CMV infection.

The European respiratory journal·2004
Same author

Thrombotic thrombocytopenic purpura: a rare cause of thrombocytopenia in HIV-infected hemophiliacs.

Annals of hematology·2003
Same author

Pulmonary manifestations of sickle cell disease.

Postgraduate medical journal·2003
Same author

Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

The New England journal of medicine·2002
Same author

Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • Thrombotic microangiopathy (TMA) is a recognized complication in individuals with Human Immunodeficiency Virus (HIV) infection.
  • Endothelial cell injury is the primary mechanism, leading to platelet activation and microvascular deposition.
  • The pathogenesis involves direct HIV cytopathic effects, malignancy, drugs, and infections.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, and management of HIV-associated TMA.
  • To discuss the diagnostic criteria and therapeutic options for HIV-TMA.
  • To evaluate the prognosis of HIV-TMA, considering the impact of HIV disease stage.

Main Methods:

  • Literature review of HIV-TMA cases.
  • Analysis of clinical features and diagnostic markers.

Related Experiment Videos

  • Evaluation of treatment efficacy, particularly plasma exchange/infusion and plasmapheresis.

    • Main Results:

    • TMA can be the initial presentation of HIV infection, not exclusively occurring in advanced stages.
    • Clinical presentation mimics idiopathic TMA, requiring suspicion in patients with new thrombocytopenia and microangiopathic hemolytic anemia.
    • Plasma exchange or infusion shows efficacy, with rapid diagnosis and plasmapheresis being crucial for favorable outcomes.

    Conclusions:

    • HIV-TMA necessitates prompt diagnosis and intervention with plasmapheresis for better outcomes.
    • The long-term prognosis remains unfavorable and is linked to the stage of HIV infection.
    • Current data on prognosis following highly active antiretroviral treatment (HAART) is limited, rendering the contemporary outlook uncertain.